Dermatologist Professor Kiran Godse joins Professor Marcus Maurer to explore the use of JAK and STAT inhibitors in the management of chronic urticaria and how these drugs may impact quality of life for people with this condition.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Utilise the following external links to access additional resources relating to the topics discussed in this episode: Role of IL-9 and IL-10 in the pathogenesis of chronic spontaneous urticaria through the JAK/STAT signalling pathway and Efficacy of Oral Ruxolitinib in a Patient with Refractory Chronic Spontaneous Urticaria.
Access additional resources by signing up to Medthority and to be notified for future ‘All Things Urticaria’ podcast episodes!
For more information about the UCARE/ACARE network and its activities, please visit: UCARE Website, UCARE LevelUp Program, ACARE Website, UCARE 4U Website, UDAY Website, CRUSE Control App and CURE Registry
Read more news regarding urticaria
Journal Club,News
April 22, 2024Join us on Thursday, May 2 from 12.00 to 12.45 pm CET, for the UCARE LevelUP Journal Club! Zhuoran Li (IFA Berlin) will speak about “DOCK2 regulates MRGPRX2/B2-mediated mast cell degranulation and drug-induced anaphylaxis” [...]
Journal Club
April 19, 2024Join us on Thursday, May 16 from 12.00 to 12.45 pm CET, for the UCARE LevelUP Journal Club! Nian Liu (IFA Berlin) will speak on “TET2 regulates immune tolerance in chronically activated mast cells” [...]
New centers,News
April 19, 2024On March 26, 2024, we welcomed Servidor Público Estadual de São Paulo Hospital, HSPE-SP Allergy Division in São Paulo, Brazil to the UCARE network. Head: Prof. Fátima Rodrigues Fernandes Deputy: Dr. Maria Elisa [...]
